serine (C60S), deubiquitinating activity was abolished. Continuous expression of DUB-I from a steroid-inducible promoter induced growth arrest in the G1 phase of the cell cycle. Cells arrested by DUB-1 expression remained viable and resumed proliferation upon steroid withdrawal. Our results suggest that DUB-1 regulates cellular growth by modulating either the ubiquitin-dependent proteolysis or the ubiquitination state of an unknown growth regulatory factor(s).
Interleukin 3 (IL-3) is a glycoprotein hormone that regulates growth of hematopoietic progenitor cells (1) . IL-3, like other cytokines, acts during the G1 phase of the cell cycle to drive cells into S phase. IL-3 exerts its biologic function through a specific receptor (IL-3R) that is expressed on its target cells (2, 3) . The IL-3R activates multiple signal transduction pathways, including the Ras-Raf-mitogen activating protein kinase pathway and the JAK-STAT pathway, resulting in the induction of immediate early genes. How these immediate early genes couple IL-3R activation to the biochemical machinery of cell growth and cell cycle progression is poorly understood.
Cell growth and cell cycle progression are controlled, at least in part, by ubiquitin-mediated proteolysis (4, 5) . Ubiquitinmediated proteolysis requires ATP and results in covalent conjugation of target proteins with multiple ubiquitin molecules (6) (7) (8) (9) . Multiubiquitinated proteins are rapidly degraded by the 26S proteasome, a multicatalytic protease complex (10, 11) . Recent evidence shows that intracellular levels of cyclins and cyclin dependent kinase inhibitors (12, 13) , as well as other growth regulatory proteins, such as p53 (14, 15) , c-Jun (16) , and IKBa (17) , are regulated by ubiquitin-mediated proteolysis. It is also possible that ubiquitination alters a protein's function without affecting its metabolic stability (18) .
Little is known about the regulatory enzymes that determine which cellular proteins are specifically destroyed by ubiquitinmediated proteolysis. Most evidence suggests that substrate specificity is determined by ubiquitin-conjugating enzymes (19, 20) . Recently, a large superfamily of genes encoding deubiquitinating enzymes was identified (21 (21) .
In the current study, we used the strategy of differential display (22, 23) (24) . Ba/F3 cells were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and 10% conditioned medium from WEHI-3B cells as a source of IL-3 (25 (25) . After 3 days in IL-3 medium, the cells were selected in IL-3 medium containing 250 /ag/ml xanthine, 15 j/g/ml hypoxanthine, 10 /tg/ml thymidine, 2 /ug/ml aminopterin, and 25 jig/ml mycophenolic acid. Gpt-resistant subclones were isolated by limiting dilution. DUB-1 expression was induced by adding 0.1 ,uM dexamethasone (diluted from 10 mM stock in ethanol). Cell proliferation and cell viability were measured by trypan blue exclusion (25) .
Analysis of Cell Cycle. Cell cycle analysis was performed by fluorescence-activated cell sorter, as previously described (30 (24, 30, 31) . By comparing mRNA from IL-3-deprived and IL-3-stimulated Ba/F3 cells (22, 23) , we initially isolated an IL-3 inducible, immediate early cDNA fragment (DUB-I). The full-length 2674-bp DUB-1 cDNA was subsequently isolated and found to contain a 1581-bp ORF (Fig. 1A ). There are two stop codons within the 183 bp of 5' untranslated region.
In addition, we isolated a murine genomic clone that contains a TATA box at position -321 and an IL-3 inducible enhancer (Y.Z., unpublished data). His domain (30) . The 3.1-kb DUB-1 mRNA appeared 30 to 60 min after addition of IL-3 ( Fig. 3) but rapidly decreased in abundance before the completion of G1 phase. DUB-1 mRNA levels were superinduced with IL-3 plus cycloheximide (data not shown), defining DUB-1 as an immediate early gene. Induction of DUB-1 mRNA was similar to that of c-myc, although c-myc mRNA levels remained elevated throughout G1 phase. Cyclin D2 mRNA accumulated later in G, phase as previously described (38 Continuous Expression of DUB-I Arrests Cellular Growth. Our initial attempts to obtain stable cell lines that constitutively express DUB-1 were unsuccessful. Because DUB-1 expression is normally turned off after only a brief period of synthesis (Fig. 3) , we reasoned that continuous expression of DUB-1 mRNA might somehow interfere with cell growth and/or viability. We therefore expressed DUB-1 in Ba/F3 cells using an inducible promoter (Fig. 4) . Twelve gptresistant Ba/F3 subclones were generated after transfection with either pMSG/DUB-1 or mutant pMSG/DUB-l(C60S), which encodes the inactive enzyme. Dexamethasone (0.1 ,uM) induced DUB-1 mRNA in all transfected cells, but not in parental or mock-transfected cells (data not shown).
Dexamethasone induced expression of the DUB-1 protein (Fig. 4A, lane 2 (Fig. 4B) . In contrast, dexamethasone-induced cells expressing DUB-1 (C60S) proliferated normally in IL-3. Importantly, while dexamethasone induction of wild-type DUB-1 inhibited cellular proliferation, as measured by total cell number, it had little effect on cellular viability ( (Fig. 4C) . To provide further evidence against nonspecific toxicity, we induced DUB-1 expression in murine 3T3 fibroblasts (data not shown). Normal cell proliferation was observed for these cells, indicating that growth suppression by DUB-1 is cell-type specific. (43) are mitogen-induced threonine/tyrosine phosphatases that inactivate mitogen activating protein kinase. p21 is a mitogen-induced inhibitor of cyclin/cdk complexes (44) . DUB-1 is the first enzyme of the ubiquitin system directly implicated in cytokine-regulated growth control.
